Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Fertil Steril. 2014 Jun;101(6):1705-10. doi: 10.1016/j.fertnstert.2014.03.016. Epub 2014 Apr 18.
To evaluate the use of fertility treatments among a large cohort of women in the United States.
Cohort study.
Nurses' Health Study II.
PATIENT(S): Ten thousand thirty-six women who reported having used fertility treatment on biennial questionnaires from 1993-2009.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Data on patterns of treatment modality were collected via self-report from validated mailed questionnaires. Information on clomiphene, gonadotropin injections alone, and gonadotropin injections as part of intrauterine insemination (IUI) and in vitro fertilization (IVF) was queried.
RESULT(S): Most women who reported fertility treatment used clomiphene (94%), with a large majority reporting clomiphene as their only form of treatment (73%). Of women who reported treatment more advanced than clomiphene, 13% had used gonadotropin injections alone, 11% IUI treatment, and 11% IVF. Several subgroups were more likely to use multiple treatment modalities and to initiate treatment with gonadotropins rather than clomiphene, including women living in states with insurance coverage of fertility procedures, with higher household income, younger in age, who remained nulliparous at the study close, and treated after 2000.
CONCLUSION(S): Results should be interpreted cautiously, but to our knowledge, this represents the first study of fertility treatment patterns in the United States and could inform public health planning.
评估美国一个大样本队列中女性使用生育治疗的情况。
队列研究。
护士健康研究 II。
1036 名女性,她们在 1993 年至 2009 年的两年一次问卷中报告使用过生育治疗。
无。
通过来自经过验证的邮寄问卷的自我报告收集治疗方式模式的数据。询问有关氯米酚、单独使用促性腺激素注射以及促性腺激素注射作为宫内授精(IUI)和体外受精(IVF)的一部分的信息。
大多数报告生育治疗的女性使用了氯米酚(94%),绝大多数报告仅使用了一种治疗方法(73%)。在报告接受比氯米酚更先进治疗的女性中,13%使用了单独的促性腺激素注射,11%接受了 IUI 治疗,11%接受了 IVF 治疗。包括在有生育治疗保险覆盖的州生活、家庭收入较高、年龄较轻、在研究结束时仍未生育且在 2000 年后接受治疗的女性在内的几个亚组更有可能使用多种治疗方式,并开始使用促性腺激素而不是氯米酚进行治疗。
结果应谨慎解释,但据我们所知,这是首次在美国进行生育治疗模式的研究,可以为公共卫生规划提供信息。